
AXP · NYSE
Consensus is Hold, backed by 27 analysts, with a reported mean target of $379 and stated low and high targets both at $382, indicating an unusually tight displayed range despite the lower mean. Morgan Stanley is the clearest named bullish voice in the supplied evidence: it maintained a Buy rating while lowering its target to $382 from $385. The evidence does not identify a named least-bullish analyst or any bearish rating. No rating or target revisions dated within the reported week were supplied, so the direction of weekly revisions is unchanged or unavailable. The substantive disagreement is whether strong growth, guidance, ROE, and innovation justify the valuation, or whether recent underperformance warrants the Hold consensus.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Morgan Stanley | — | $382 | +16.5% | Jul 27, 2026 | Open the report this row came from |